by PRISMS | May 28, 2020 | Research Study
Smith-Magenis Syndrome is a genetic disorder most commonly caused by a deletion of chromosome 17p11.2, and less commonly by mutations in the RAI1 gene Ongoing projects in Dr. Sarah Elsea’s lab are focused on understanding the function of...
by PRISMS | May 28, 2020 | Research Study
Rhythm Pharmaceuticals is currently recruiting for a Phase 2 clinical study of an investigational therapy to help reduce weight and hunger in individuals diagnosed with Smith-Magenis Syndrome and rare genetic diseases of obesity. The study is enrolling individuals:...
